Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outcomes Measurement Congenital Heart Disease Working Group.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
21 07 2021
Historique:
received: 30 11 2020
revised: 17 01 2021
accepted: 03 02 2021
pubmed: 13 2 2021
medline: 30 3 2022
entrez: 12 2 2021
Statut: ppublish

Résumé

Congenital heart disease (CHD) is the most common congenital malformation. Despite the worldwide burden to patient wellbeing and health system resource utilization, tracking of long-term outcomes is lacking, limiting the delivery and measurement of high-value care. To begin transitioning to value-based healthcare in CHD, the International Consortium for Health Outcomes Measurement aligned an international collaborative of CHD experts, patient representatives, and other stakeholders to construct a standard set of outcomes and risk-adjustment variables that are meaningful to patients. The primary aim was to identify a minimum standard set of outcomes to be used by health systems worldwide. The methodological process included four key steps: (i) develop a working group representative of all CHD stakeholders; (ii) conduct extensive literature reviews to identify scope, outcomes of interest, tools used to measure outcomes, and case-mix adjustment variables; (iii) create the outcome set using a series of multi-round Delphi processes; and (iv) disseminate set worldwide. The Working Group established a 15-item outcome set, incorporating physical, mental, social, and overall health outcomes accompanied by tools for measurement and case-mix adjustment variables. Patients with any CHD diagnoses of all ages are included. Following an open review process, over 80% of patients and providers surveyed agreed with the set in its final form. This is the first international development of a stakeholder-informed standard set of outcomes for CHD. It can serve as a first step for a lifespan outcomes measurement approach to guide benchmarking and improvement among health systems.

Identifiants

pubmed: 33576374
pii: 6129042
doi: 10.1093/ehjqcco/qcab009
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-365

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Kevin Hummel (K)

Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Department of Pediatric Cardiology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, USA.

Sarah Whittaker (S)

International Consortium for Health Outcomes Measurement, Cambridge, MA, USA.

Nick Sillett (N)

International Consortium for Health Outcomes Measurement, Cambridge, MA, USA.

Amy Basken (A)

Pediatric Congenital Heart Association, Madison, WI, USA.
Conquering CHD, Madison, WI, USA.

Malin Berghammer (M)

Queen Silvia Children Hospital/Sahlgrenska University Hospital, Gothenburg, Sweden.
University West, Trollhättan, Sweden.

Tomás Chalela (T)

Fundacion Cardiofantil, Bogota, Colombia.

Julie Chauhan (J)

All India Institute of Medical Sciences, New Delhi, India.

Luis Antonio Garcia (LA)

Kardias A.C. Foundation, Mexico City, Mexico.

Babar Hasan (B)

Department of Pediatrics, Aga Khan University, Karachi City, Pakistan.

Kathy Jenkins (K)

Department of Pediatric Cardiology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, USA.

Laila Akbar Ladak (LA)

Department of Pediatrics, Aga Khan University, Karachi City, Pakistan.
Susan Wakil School of Nursing, The University of Sydney, Sydney, Australia.

Nicolas Madsen (N)

Department of Cardiology, Cincinnati Children's Hospital, Cincinnati, OH, USA.

Almudena March (A)

Kardias A.C. Foundation, Mexico City, Mexico.

Disty Pearson (D)

Department of Pediatric Cardiology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, USA.

Steven M Schwartz (SM)

Department of Cardiology, The Hospital for Sick Children, Toronto, ON, Canada.

James D St Louis (JD)

Department of Surgery, Medical College of Georgia, Augusta, GA, USA.

Ingrid van Beynum (I)

Department of Pediatric Cardiology, Erasmus Medical Centre, Rotterdam, Netherlands.
Sophia Children's Hospital, Rotterdam, Netherlands.

Amy Verstappen (A)

Global Alliance for Rheumatic and Congenital Hearts, Philadelphia PA, USA.

Roberta Williams (R)

Department of Cardiology, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Bistra Zheleva (B)

Children's HeartLink, Minneapolis, MN, USA.

Lisa Hom (L)

Department of Cardiology, Children's National Hospital, Washington, DC, USA.

Gerard R Martin (GR)

Department of Cardiology, Children's National Hospital, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH